{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T07:33:53Z","timestamp":1782286433994,"version":"3.54.5"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2018,9]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of the Report<\/jats:title>\n            <jats:p>Distinguishing between amiodarone-induced thyrotoxicosis (AIT) caused by excessive hormone synthesis (AIT-1) or by a destructive process (AIT-2) has important therapeutic implications, but is still difficult and debated. <jats:sup>99m<\/jats:sup>Tc-sestaMIBI thyroid scintigraphy (99m-STS) has been proposed as a tool for classifying the two forms.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Material and Methods<\/jats:title>\n            <jats:p>30 AIT patients (11 females and 19 males) who underwent 99m-STS were retrospectively assessed for the present study. For each patient, a target-to-background ratio (TBR) was obtained on planar images. The TBR was then correlated with the qualitative assessment of the scans and the final clinical diagnosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Considering clinical response to treatment as the gold standard for differential diagnosis, 14 cases of AIT-1, 12 of AIT-2, and 4 mixed forms were identified. 99m-STS was able to qualitatively identify all the mixed forms, while 1\/14 AIT-1 and 6\/12 AIT-2 cases were misdiagnosed as mixed forms. When the quantitative index (the TBR) was compared with the final clinical diagnosis, ROC curve analysis enabled us to identify an IBR of 0.482 during 99m-STS as a cut-off capable of discriminating between AIT-1 and AIT-2, with 100% specificity and 91.7% sensitivity (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.0001, area under the curve: 0.982).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Taking the TBR into consideration, 99m-STS proved a very useful tool for distinguishing AIT-1 from AIT-2, and thus offering patients appropriate treatment as of their diagnosis. This approach can avoid pointless and potentially dangerous combined overtreatments, and may speed up the return to normal thyroid function, which is crucial in AIT patients suffering from heart disease.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rlu.0000000000002207","type":"journal-article","created":{"date-parts":[[2018,7,23]],"date-time":"2018-07-23T09:17:11Z","timestamp":1532337431000},"page":"655-662","source":"Crossref","is-referenced-by-count":20,"title":["Amiodarone-Induced Thyrotoxicosis"],"prefix":"10.1097","volume":"43","author":[{"given":"Simona","family":"Censi","sequence":"first","affiliation":[{"name":"Endocrinology Unit, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Bodanza","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Unit, University of Padua, Padova, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Manso","sequence":"additional","affiliation":[{"name":"Endocrinology Unit, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Gusella","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Unit, University of Padua, Padova, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Watutantrige-Fernando","sequence":"additional","affiliation":[{"name":"Endocrinology Unit, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Cavedon","sequence":"additional","affiliation":[{"name":"Endocrinology Unit, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susi","family":"Barollo","sequence":"additional","affiliation":[{"name":"Endocrinology Unit, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loris","family":"Bertazza","sequence":"additional","affiliation":[{"name":"Endocrinology Unit, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Cecchin","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Unit, University of Padua, Padova, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Mian","sequence":"additional","affiliation":[{"name":"Endocrinology Unit, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib1-20230925","first-page":"513","article-title":"Pharmacokinetics and body distribution of amiodarone in man","volume":"34","year":"1984","journal-title":"Arzneimittelforschung"},{"key":"bib2-20230925","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.beem.2009.07.001","article-title":"Amiodarone and thyroid","volume":"23","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"bib3-20230925","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1210\/jcem-53-5-997","article-title":"Hyperthyroxinemia with bradycardia and normal thyrotropin secretion after chronic amiodarone administration","volume":"53","year":"1981","journal-title":"J Clin Endocrinol Metab"},{"key":"bib4-20230925","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1210\/endo-115-4-1605","article-title":"Amiodarone inhibits the conversion of thyroxine to triiodothyronine in isolated rat hepatocytes","volume":"115","year":"1984","journal-title":"Endocrinology"},{"key":"bib5-20230925","first-page":"193","article-title":"Thyroxine and triiodothyronine kinetics in cardiac patients taking amiodarone","volume":"111","year":"1986","journal-title":"Acta Endocrinol (Copenh)"},{"key":"bib6-20230925","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.0300-0664.2001.01458.x","article-title":"Amiodarone-induced thyrotoxicosis: a difficult diagnostic and therapeutic challenge","volume":"56","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"bib7-20230925","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/hrt.79.2.121","article-title":"Amiodarone and the thyroid: a practical guide to the management of thyroid dysfunction induced by amiodarone therapy","volume":"79","year":"1998","journal-title":"Heart"},{"key":"bib8-20230925","first-page":"240","article-title":"The effects of amiodarone on the thyroid","volume":"22","year":"2001","journal-title":"Endocr Rev"},{"key":"bib9-20230925","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000486957","article-title":"2018 European Thyroid Association (ETA) Guidelines for the Management of Amiodarone-Associated Thyroid Dysfunction","volume":"7","year":"2018","journal-title":"Eur Thyroid J"},{"key":"bib10-20230925","first-page":"340","article-title":"Amiodarone and the thyroid: a 2012 update","volume":"35","year":"2012","journal-title":"J Endocrinol Invest"},{"key":"bib11-20230925","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1089\/105072501300176471","article-title":"The various effects of amiodarone on thyroid function","volume":"11","year":"2001","journal-title":"Thyroid"},{"key":"bib12-20230925","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1210\/jc.2008-1907","article-title":"Amiodarone-induced thyrotoxicosis is a predictor of adverse cardiovascular outcome","volume":"94","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"bib13-20230925","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1530\/eje.1.02122","article-title":"Amiodarone-induced thyrotoxicosis: left ventricular dysfunction is associated with increased mortality","volume":"154","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"bib14-20230925","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1161\/01.CIR.0000085166.44904.79","article-title":"Natural history of asymptomatic left ventricular systolic dysfunction in the community","volume":"108","year":"2003","journal-title":"Circulation"},{"key":"bib15-20230925","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1210\/jc.2011-1678","article-title":"Continuation of amiodarone delays restoration of euthyroidism in patients with type 2 amiodarone-induced thyrotoxicosis treated with prednisone: a pilot study","volume":"96","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"bib16-20230925","first-page":"1402","article-title":"Twenty-four hour radioactive iodine uptake in 35 patients with amiodarone associated thyrotoxicosis","volume":"26","year":"1985","journal-title":"J Nucl Med"},{"key":"bib17-20230925","first-page":"423","article-title":"Serum interleukin-6 in amiodarone-induced thyrotoxicosis","volume":"78","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"bib18-20230925","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1210\/jc.2010-0180","article-title":"Approach to the patient with amiodarone-induced thyrotoxicosis","volume":"95","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"bib19-20230925","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1089\/thy.1997.7.541","article-title":"Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis","volume":"7","year":"1997","journal-title":"Thyroid"},{"key":"bib20-20230925","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1530\/EJE-08-0348","article-title":"The usefulness of 99mTc-sestaMIBI thyroid scan in the differential diagnosis and management of amiodarone-induced thyrotoxicosis","volume":"159","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"bib21-20230925","doi-asserted-by":"crossref","first-page":"20160836","DOI":"10.1259\/bjr.20160836","article-title":"Evaluation of 99mTc-MIBI in thyroid gland imaging for the diagnosis of amiodarone-induced thyrotoxicosis","volume":"90","year":"2017","journal-title":"Br J Radiol"},{"key":"bib22-20230925","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.jacc.2007.02.054","article-title":"Amiodarone-induced thyrotoxicosis: clinical course and predictors of outcome","volume":"49","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"bib23-20230925","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.amjmed.2004.11.028","article-title":"Amiodarone and the thyroid","volume":"118","year":"2005","journal-title":"Am J Med"},{"key":"bib24-20230925","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1210\/jcem.86.1.7119","article-title":"Amiodarone-induced thyrotoxicosis","volume":"86","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"bib25-20230925","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1365-2265.2004.02119.x","article-title":"Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association","volume":"61","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"bib26-20230925","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1089\/105072503321319521","article-title":"A stepwise approach to the treatment of amiodarone-induced thyrotoxicosis","volume":"13","year":"2003","journal-title":"Thyroid"},{"key":"bib27-20230925","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1210\/jc.2009-0940","article-title":"Glucocorticoids are preferable to thionamides as first-line treatment for amiodarone-induced thyrotoxicosis due to destructive thyroiditis: a matched retrospective cohort study","volume":"94","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"bib28-20230925","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/MNM.0000000000000260","article-title":"Quantitative assessment of thyroid-to-background ratio improves the interobserver reliability of technetium-99m sestamibi thyroid scintigraphy for investigation of amiodarone-induced thyrotoxicosis","volume":"36","year":"2015","journal-title":"Nucl Med Commun"},{"key":"bib29-20230925","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1046\/j.1445-5994.2003.00463.x","article-title":"Heterogeneity of amiodarone-induced thyrotoxicosis: evaluation of colour-flow Doppler sonography in predicting therapeutic response","volume":"33","year":"2003","journal-title":"Intern Med J"},{"key":"bib30-20230925","first-page":"159","article-title":"The way forward in Italy for iodine","volume":"108","year":"2017","journal-title":"Minerva Med"},{"key":"bib31-20230925","doi-asserted-by":"crossref","first-page":"839","DOI":"10.4158\/EP13180.RA","article-title":"Iodine deficiency and excess in children: worldwide status in 2013","volume":"19","year":"2013","journal-title":"Endocr Pract"},{"key":"bib32-20230925","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1007\/s00259-013-2387-x","article-title":"EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry II. Dosimetry prior to radioiodine therapy of benign thyroid diseases","volume":"40","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib33-20230925","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1365-2265.2011.04087.x","article-title":"Determinants and outcome of amiodarone-associated thyroid dysfunction","volume":"75","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"bib34-20230925","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0002-9343(91)90187-3","article-title":"Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism","volume":"91","year":"1991","journal-title":"Am J Med"},{"key":"bib35-20230925","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1001\/archinte.160.12.1741","article-title":"Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology","volume":"160","year":"2000","journal-title":"Arch Intern Med"},{"key":"bib36-20230925","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.clpt.2003.09.010","article-title":"Monitoring amiodarone\u2019s toxicities: recommendations, evidence, and clinical practice","volume":"75","year":"2004","journal-title":"Clin Pharmacol Ther"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003072-201809000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T05:07:04Z","timestamp":1695618424000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201809000-00004"}},"subtitle":["Differential Diagnosis Using 99mTc-SestaMIBI and Target-to-Background Ratio (TBR)"],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000002207","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]}}}